CA
GILD icon

Claro Advisors’s Gilead Sciences GILD Stock Holding History

Claro Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-600
Closed -$1K – 466
2018
Q4 		$1K Buy
+600
New +$41.9K ﹤0.01% 1009

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Claro Advisors's GILD Position: Q1 2026 in Review

Claro Advisors opened a new position in Gilead Sciences (GILD) in Q1 2026: 4,194 shares worth $585K. The stake represents 0.07% of the portfolio and ranks #212 among its holdings. This is a return to the name: Claro Advisors previously reported a position in GILD as recently as Q2 2025.

Claro Advisors first reported a position in GILD in Q4 2018 and has held it in 28 quarters since. The position peaked at $1.22M in Q1 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Claro Advisors held 4,194 shares of Gilead Sciences worth $585K as of Q1 2026.
  • Gilead Sciences was a new Claro Advisors position in Q1 2026.
  • Gilead Sciences made up 0.07% of Claro Advisors's portfolio in Q1 2026, its #212 holding.
  • Claro Advisors first reported a position in Gilead Sciences in Q4 2018 and has held it in 28 quarters since.
  • Claro Advisors's Gilead Sciences position peaked at $1.22M in Q1 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.